Acunivive 15 (ketorolac tromethamine)
(KETOROLAC TROMETHAMINE)IT3 Medical LLC
Usage: Ketorolac tromethamine is indicated for short-term management (≤5 days) of moderately severe acute pain requiring analgesia equivalent to opioids, typically postoperatively. Initial therapy should be via IV or IM; oral ketorolac is for continuation only. Total use must not exceed 5 days to mitigate adverse reactions.